Sinergium Biotech, an Argentinian manufacturer, will lead this effort, leveraging the WHO and MPP mRNA Technology Transfer Programme to achieve the objective.
The self-test version, specifically designed for use by lay users, provides individuals with a single kit containing the components that are needed to perform the self-test.
Researchers develop new model to understand how stress and coping mechanisms influence alcohol dependence.
A new report reveals that alcohol is a leading cause of death through drunk driving, violence, and numerous diseases.
The nation’s Institute of Infectious Diseases recorded over 977 cases of streptococcal toxic shock syndrome in 2024, surpassing last year’s total of 941.
The continent still falls short of the WHO’s recommended collection target of 10 units of blood per 1000 people.
WHO urges stronger measures to protect African youth from tobacco industry’s influence, noting seven million young users and ongoing health risks.
Developing countries like Nigeria lose highly trained health professionals to developed nations, highlighting global health inequities.
The collaboration will focus on boosting regional vaccine research, development, and manufacturing capabilities, fostering a faster and more equitable response to emerging infectious diseases.
STIs, including multi-resistant gonorrhoea, are increasing globally, with the highest spikes in the Americas and Africa.
The World Health Organization (WHO) has added a new weapon to the fight against dengue, a mosquito-borne illness affecting millions globally.
Namibia’s achievement follows a concerted strategy to curb the transmission of hepatitis B, HIV, and syphilis.
Eight African countries now offer the lifesaving malaria vaccine, with Benin, Liberia, and Sierra Leone joining the fight. This WHO-backed effort aims to significantly reduce childhood illness and death from malaria.
Study reveals vaccines’ unparalleled impact, saving six lives per minute over 50 years.